Updated 07:15 GMT, 17 Nov 2026 SPX 7,416.59 -1.92% NDX 27,197.15 -2.67% VIX 22.91 +18.70% GOLD 3,880.40 +0.71% CL 84.81 -1.06% BTC 64,554.96 -0.46%
NAS100 27,197 −2.67% S&P 7,417 −1.92% GOLD $3,880 +0.71% BTC $64,555 −0.46% VIX 22.91 +18.70% latest tape · as of 07:15 UTC
The Screen · Financials · Information Technology Services

Jack Henry & Associates logoJack Henry & Associates

JKHY · a US exchange · USD · Market cap $12.2B · 7,300 employees

Jack Henry & Associates, Inc.

FAIL · Does not pass the screen
177.67 USD

Price as of 13 Nov 2026Daily close, not a live quoteLast reviewed 4 days ago

Screened 2026-11-13 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price177.67 USD at the 13 Nov 2026 close
  • Our value readOvervalued vs our fair value, as of 13 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • OptionsOpen interest leans to puts (put/call 1.02)
  • Last reviewed13 Nov 2026 (4 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $151.20 to $181.81, base estimate $158.09 (screen dated 2026-11-13).

Current read
Markup ?
Overvalued · screened 2026-11-13
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 1.02, read 2026-11-14
  • Ethical does not pass the values gate
Price177.67 USD
Fair value158.09
Ethical score10.0/100
Value readOvervaluedas of 13 Nov 2026
Our investment reviews on this name
2026-10-27Read Markup153.19+16.0% to today ✓Accumulation gives way to Markup first Markup read since September
2026-10-21Read Accumulation153.19+16.0% to today ✓Distribution gives way to Accumulation
2026-10-02Read Distribution146.22+21.5% to today Markup gives way to Distribution after a 5% slide in 9 weeks
2026-08-03Read Markup154.24+15.2% to today ✓Distribution gives way to Markup after a 19% rise in 5 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Jack Henry & Associates holds its Markup at $177.67. The statistical read favours the sellers, held for 1 days.

As held on the ledger · 2026-11-13
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 1 days
Price at the screen$177.67
Valuation24.16 trailing · 21.99 forward price to earnings
Values screenFAIL · score 10.0
Beta0.54
The Workings

Five Screens, Shown in Full

Does not pass. Business activity screen

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Business activity: Financials sector Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

Jack Henry & Associates does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-15. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when JKHY's ethical verdict changes

Today JKHY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Overvalued vs our fair value, as of 13 Nov 2026: it trades above our $158.09 fair value estimate, strong competitive moat, 8.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

151.20Conservative158.09Base case181.81Growth case 177.67Price

Fair value range in USD, drawn from the 2026-11-13 screen. The gold marker is the market price at the same screen. The price runs 12.4% above the base estimate.

The Street's Range
168.00Street low 197.00Street average 220.00Street high 177.67Price

Third-party analyst targets: 19 covering, consensus Buy. The average target sits +11% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $158.09, with a range of $151.20 to $181.81, dated to the 2026-11-13 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Jack Henry powers bank systems yet fails ethically

Jack Henry keeps the back-office systems running for thousands of smaller banks every day. The numbers show a strong moat, 25% returns on equity, 21% profit margins and 9% revenue growth, yet we pass because the ethical screen flags the business outright.

Forward earnings sit at 21.4 times while the shares trade 6% above our fair value of 142.03. Fourteen analysts still lean buy with a median target near 184, but none of that overrides the screen result.

Any regulatory tightening on payment flows or loss of a few large clients could hit growth fast. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E22.0xexpensive even after accounting for its growth
Trailing P/E24.2xa premium valuation
EPS, trailing7.28
EPS, forward8.00
Revenue growth+8.8%steady growth
Profit margin20.0%healthy profit margins
Return on equity24.3%an exceptional return on shareholder capital
FCF yield3.30%
Dividend yield1.70%
Debt to equity0.06minimal debt: a conservative balance sheet
Current ratio1.38adequate liquidity, worth monitoring
Beta0.54steadier than the market
Short interest, float0.07%
52-week range121.04 - 193.39
MoatSTRONG
Market cap$12.2B
Employees7,300

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

JKHY trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-10 Markup $171.20 +6.1% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189.

2026-11-03 Markup $161.34 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-02 Markup $161.34 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-11-01 Markup $161.34 -0.7% Entry 14

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-31 Markup $162.55 +0.0% Entry 13

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-30 Markup $162.55 +0.0% Entry 12

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-29 Markup $162.55 +6.1% Entry 11

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-28 Markup $153.19 +0.0% Entry 10

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup · changed $153.19 +0.0% Entry 9

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Accumulation · changed $153.19 +2.6% Entry 8

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 28%. Our forward projection puts the odds of a 10% gain over the next month near 9%. The street (14 analysts) rates it buy, with a mean price target of $189.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on JKHY

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in JKHY's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · JKHY
DateInsiderTitleTypeSharesValue
2026-05-14 ADELSON GREGORY R. Chief Executive Officer 2,000 $266,840
2026-05-14 CARSLEY MIMI Chief Financial Officer 375 $50,295
2026-02-12 FLANIGAN MATTHEW C Director 440 ·
2025-12-31 MCLACHLAN SHANON G. Chief Operating Officer 183 ·
2025-12-15 SWEARINGEN RENEE ANN Officer 200 ·
2025-12-01 FOSS DAVID B Director 20,000 $3,498,400
2025-11-11 FLANIGAN MATTHEW C Director 1,159 ·
2025-11-11 BROWN WESLEY A Director 1,159 ·
2025-11-11 WILSON THOMAS HAMPTON JR. Director 1,159 ·
2025-11-11 WIMSETT THOMAS A Director 1,159 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming JKHY
DatePoliticianPartyTypeAmount
2026-06-16 Gil Cisneros Democrat buy 1K–15K
2024-05-03 Tommy Tuberville Republican sell 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $143.01 -10.7% $0.61 $898 -10.2%
2 months $146.54 -12.8% $0.61 $876 -12.4%
3 months $165.60 -22.9% $0.61 $775 -22.5%
6 months $185.67 -31.2% $1.22 $695 -30.5%
1 year $176.83 -27.8% $2.38 $736 -26.4%
2 years $159.55 -19.9% $4.64 $830 -17.0%
3 years $151.55 -15.7% $6.78 $888 -11.2%
5 years $152.50 -16.2% $10.70 $908 -9.2%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever JKHY does next, these words stay.

Jack Henry & Associates · JKHY · Markup · $177.67
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.